Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mehra

Showing results (581-590 of 780) with videos related to

Pageof 78
Sort By:
JACC. Cardiovascular Interventions|April 29, 2026
Percutaneous Thrombectomy for LVAD Inflow and Outflow ThrombosisRené Boudreau, Avinainder Singh, Ameesh Isath, et al.
Journal of the American Heart Association|November 7, 2012
Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HFGregg C Fonarow, Nancy M Albert, Anne B Curtis, et al.
JACC. Heart Failure|October 30, 2020
Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support: An ELSO Registry AnalysisMabel Chung, Fausto R Cabezas, Jose I Nunez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 28, 2014
Scientific progress in heart and lung failure, mechanical circulatory support, and transplantation: highlights from the Journal of Heart and Lung TransplantationKeyur B Shah, Johanna M Kwakkel-van Erp, Christina Migliore, et al.
American Heart Journal|June 2, 2007
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMACMandeep R Mehra, Ted McCluskey, Mark Barr, et al.
JAMA|September 8, 2022
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized TrialMandeep R Mehra, Daniel J Goldstein, Joseph C Cleveland, et al.
SAGE Open Medicine|July 25, 2020
Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantationChristina L Kaufman, Jean Kanitakis, Annemarie Weissenbacher, et al.
Journal of the American College of Cardiology|May 1, 1997
Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopyM R Mehra, H O Ventura, S P Jain, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2017
Early aspirin use and the development of cardiac allograft vasculopathyMiae Kim, Brian A Bergmark, Thomas A Zelniker, et al.
European Journal of Heart Failure|June 18, 2021
Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trialMandeep R Mehra, Daniel L Crandall, Finn Gustafsson, et al.
Pageof 78

Showing results (581-590 of 780) with videos related to

Sort By:
Pageof 78
JACC. Cardiovascular Interventions|April 29, 2026
Percutaneous Thrombectomy for LVAD Inflow and Outflow ThrombosisRené Boudreau, Avinainder Singh, Ameesh Isath, et al.
Journal of the American Heart Association|November 7, 2012
Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HFGregg C Fonarow, Nancy M Albert, Anne B Curtis, et al.
JACC. Heart Failure|October 30, 2020
Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support: An ELSO Registry AnalysisMabel Chung, Fausto R Cabezas, Jose I Nunez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 28, 2014
Scientific progress in heart and lung failure, mechanical circulatory support, and transplantation: highlights from the Journal of Heart and Lung TransplantationKeyur B Shah, Johanna M Kwakkel-van Erp, Christina Migliore, et al.
American Heart Journal|June 2, 2007
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMACMandeep R Mehra, Ted McCluskey, Mark Barr, et al.
JAMA|September 8, 2022
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized TrialMandeep R Mehra, Daniel J Goldstein, Joseph C Cleveland, et al.
SAGE Open Medicine|July 25, 2020
Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantationChristina L Kaufman, Jean Kanitakis, Annemarie Weissenbacher, et al.
Journal of the American College of Cardiology|May 1, 1997
Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopyM R Mehra, H O Ventura, S P Jain, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2017
Early aspirin use and the development of cardiac allograft vasculopathyMiae Kim, Brian A Bergmark, Thomas A Zelniker, et al.
European Journal of Heart Failure|June 18, 2021
Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trialMandeep R Mehra, Daniel L Crandall, Finn Gustafsson, et al.
Pageof 78